L. Choo

Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk

I. James, A. Kermode, W. Carroll, 2014, Multiple sclerosis.

New genetic predictors for abacavir tolerance in HLA-B*57:01 positive individuals.

I. James, S. Mallal, J. Montaner, 2020, Human immunology.

Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis

I. James, A. Kermode, W. Carroll, 2016, PloS one.

A Rapid Allele-Specific Assay for HLA-A*32:01 to Identify Patients at Risk for Vancomycin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms.

S. Mallal, C. Shaffer, E. Phillips, 2019, The Journal of molecular diagnostics : JMD.

SARS-CoV-2 seroprevalence and antibody trends in vaccinated, multi-ethnic healthcare employees.

N. S. Zulkufli, L. Choo, K. Cheng, 2021, Tropical biomedicine.

A low‐cost, sensitive and specific PCR‐based tool for rapid clinical detection of HLA‐B*35 alleles associated with delayed drug hypersensitivity reactions

Andrew Gibson, A. Chopra, Pooja Deshpande, 2022, HLA.